Similar articles

• Role of platelet factor 3 in the hypercoagulability induced by pregnancy and oral contraceptives.

  Renaud S, Gautheron P. Renaud S, et al. Thromb Diath Haemorrh. 1973 Nov;30(2):299-306. Thromb Diath Haemorrh. 1973. PMID: 4797961 No abstract available.
• [Changes in the heparinocyte count during intake of hormonal contraceptives].

  Frick G, Kühne D. Frick G, et al. Zentralbl Gynakol. 1973 Oct 12;95(41):1441-50. Zentralbl Gynakol. 1973. PMID: 4129504 German. No abstract available.
• The relationship of clotting factors to dosage levels of estrogen and progestogen-like combinations.

  Banks AL, Rutherford RN, Coburn WA, Welsh RL. Banks AL, et al. Int J Fertil. 1966 Jul-Sep;11(3):277-80. Int J Fertil. 1966. PMID: 5967993 No abstract available.
• Oral contraceptives and thromboembolism.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 1972 Aug 18;14(17):61-2. Med Lett Drugs Ther. 1972. PMID: 4567564 Review. No abstract available.
• [Comparative study of the effect of ethinyl estradiol and mestranol. Clinical data from the literature].

  Pellegrini R, Seassaro E. Pellegrini R, et al. Quad Clin Ostet Ginecol. 1969 Sep;24(9):597-617. Quad Clin Ostet Ginecol. 1969. PMID: 4926507 Review. Italian. No abstract available.